Power Law company profile

Aliada Therapeutics

Biotech & Life Sciences · Boston, United States · Founded 2021 Unicorn

Developing drugs for the treatment of diseases of the central nervous system (cns)

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Global footprint

Where Aliada Therapeutics has talent and traffic

Workforce by country

🇺🇸 United States · Boston HQ

Book a demo for the full country breakdown

Web traffic by country

110 monthly visits
across markets

🇺🇸 United States90.9%

Top 1 markets shown

Patent intelligence

$213k patent portfolio · 3 active families

Estimated portfolio value

$213k

0.02% of valuation · 1154.9× smaller than top peer Arrowhead Pharmaceuticals ($246M)

3 active patent families

Where Aliada Therapeutics innovates Nucleic acidMonoclonalAnti antibodyAntigen Binding FragmentAntiendomysial antibodies

Where Aliada Therapeutics concentrates vs peers

Each axis is a top-10 topic across Aliada Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Aliada Therapeutics

An AI-synthesized read of the highest-engagement posts about Aliada Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aliada Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles